158 related articles for article (PubMed ID: 31894641)
1. Human Tumor-Lymphatic Microfluidic Model Reveals Differential Conditioning of Lymphatic Vessels by Breast Cancer Cells.
Ayuso JM; Gong MM; Skala MC; Harari PM; Beebe DJ
Adv Healthc Mater; 2020 Feb; 9(3):e1900925. PubMed ID: 31894641
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional profiling of breast cancer-associated lymphatic vessels reveals VCAM-1 as regulator of lymphatic invasion and permeability.
Dieterich LC; Kapaklikaya K; Cetintas T; Proulx ST; Commerford CD; Ikenberg K; Bachmann SB; Scholl J; Detmar M
Int J Cancer; 2019 Nov; 145(10):2804-2815. PubMed ID: 31344266
[TBL] [Abstract][Full Text] [Related]
3. Human organotypic lymphatic vessel model elucidates microenvironment-dependent signaling and barrier function.
Gong MM; Lugo-Cintron KM; White BR; Kerr SC; Harari PM; Beebe DJ
Biomaterials; 2019 Sep; 214():119225. PubMed ID: 31154151
[TBL] [Abstract][Full Text] [Related]
4. Macrophage-derived interleukin-1beta promotes human breast cancer cell migration and lymphatic adhesion in vitro.
Storr SJ; Safuan S; Ahmad N; El-Refaee M; Jackson AM; Martin SG
Cancer Immunol Immunother; 2017 Oct; 66(10):1287-1294. PubMed ID: 28551814
[TBL] [Abstract][Full Text] [Related]
5. Conditioned medium from stimulated macrophages inhibits growth but induces an inflammatory phenotype in breast cancer cells.
Song W; Thakor P; Vesey DA; Gobe GC; Morais C
Biomed Pharmacother; 2018 Oct; 106():247-254. PubMed ID: 29966967
[TBL] [Abstract][Full Text] [Related]
6. Docetaxel facilitates lymphatic-tumor crosstalk to promote lymphangiogenesis and cancer progression.
Harris AR; Perez MJ; Munson JM
BMC Cancer; 2018 Jul; 18(1):718. PubMed ID: 29976154
[TBL] [Abstract][Full Text] [Related]
7. ELK3 expressed in lymphatic endothelial cells promotes breast cancer progression and metastasis through exosomal miRNAs.
Kim KS; Park JI; Oh N; Cho HJ; Park JH; Park KS
Sci Rep; 2019 Jun; 9(1):8418. PubMed ID: 31182803
[TBL] [Abstract][Full Text] [Related]
8. Matrix density drives 3D organotypic lymphatic vessel activation in a microfluidic model of the breast tumor microenvironment.
Lugo-Cintrón KM; Ayuso JM; White BR; Harari PM; Ponik SM; Beebe DJ; Gong MM; Virumbrales-Muñoz M
Lab Chip; 2020 May; 20(9):1586-1600. PubMed ID: 32297896
[TBL] [Abstract][Full Text] [Related]
9. Adipocyte hypoxia promotes epithelial-mesenchymal transition-related gene expression and estrogen receptor-negative phenotype in breast cancer cells.
Yao-Borengasser A; Monzavi-Karbassi B; Hedges RA; Rogers LJ; Kadlubar SA; Kieber-Emmons T
Oncol Rep; 2015 Jun; 33(6):2689-94. PubMed ID: 25823469
[TBL] [Abstract][Full Text] [Related]
10. Depletion of carbonic anhydrase IX abrogates hypoxia-induced overexpression of stanniocalcin-1 in triple negative breast cancer cells.
Zandberga E; Zayakin P; Ābols A; Pūpola D; Trapencieris P; Linē A
Cancer Biol Ther; 2017 Aug; 18(8):596-605. PubMed ID: 28665755
[TBL] [Abstract][Full Text] [Related]
11. Long-Lived Human Lymphatic Endothelial Cells to Study Lymphatic Biology and Lymphatic Vessel/Tumor Coculture in a 3D Microfluidic Model.
Frenkel N; Poghosyan S; Alarcón CR; García SB; Queiroz K; van den Bent L; Laoukili J; Rinkes IB; Vulto P; Kranenburg O; Hagendoorn J
ACS Biomater Sci Eng; 2021 Jul; 7(7):3030-3042. PubMed ID: 34185991
[TBL] [Abstract][Full Text] [Related]
12. NOTCH3 expression is linked to breast cancer seeding and distant metastasis.
Leontovich AA; Jalalirad M; Salisbury JL; Mills L; Haddox C; Schroeder M; Tuma A; Guicciardi ME; Zammataro L; Gambino MW; Amato A; Di Leonardo A; McCubrey J; Lange CA; Liu M; Haddad T; Goetz M; Boughey J; Sarkaria J; Wang L; Ingle JN; Galanis E; D'Assoro AB
Breast Cancer Res; 2018 Sep; 20(1):105. PubMed ID: 30180881
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of Tumor-Lymphatic Interactions in Invasive Breast and Prostate Carcinoma.
Oliveira-Ferrer L; Milde-Langosch K; Eylmann K; Rossberg M; Müller V; Schmalfeldt B; Witzel I; Wellbrock J; Fiedler W
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963450
[TBL] [Abstract][Full Text] [Related]
14. Over expressing miR-19b-1 suppress breast cancer growth by inhibiting tumor microenvironment induced angiogenesis.
Yin R; Guo L; Gu J; Li C; Zhang W
Int J Biochem Cell Biol; 2018 Apr; 97():43-51. PubMed ID: 29425833
[TBL] [Abstract][Full Text] [Related]
15. HMGA1 promotes breast cancer angiogenesis supporting the stability, nuclear localization and transcriptional activity of FOXM1.
Zanin R; Pegoraro S; Ros G; Ciani Y; Piazza S; Bossi F; Bulla R; Zennaro C; Tonon F; Lazarevic D; Stupka E; Sgarra R; Manfioletti G
J Exp Clin Cancer Res; 2019 Jul; 38(1):313. PubMed ID: 31311575
[TBL] [Abstract][Full Text] [Related]
16. Validation of a network-based strategy for the optimization of combinatorial target selection in breast cancer therapy: siRNA knockdown of network targets in MDA-MB-231 cells as an in vitro model for inhibition of tumor development.
Tilli TM; Carels N; Tuszynski JA; Pasdar M
Oncotarget; 2016 Sep; 7(39):63189-63203. PubMed ID: 27527857
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of transcription factor Fra-1 in ER-positive breast cancer: contribution to a metastatic phenotype through modulation of tumor cell adhesive properties.
Oliveira-Ferrer L; Kürschner M; Labitzky V; Wicklein D; Müller V; Lüers G; Schumacher U; Milde-Langosch K; Schröder C
J Cancer Res Clin Oncol; 2015 Oct; 141(10):1715-26. PubMed ID: 25666264
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
19. Vascularized microfluidic platforms to mimic the tumor microenvironment.
Michna R; Gadde M; Ozkan A; DeWitt M; Rylander M
Biotechnol Bioeng; 2018 Nov; 115(11):2793-2806. PubMed ID: 29940072
[TBL] [Abstract][Full Text] [Related]
20. Wnt pathway targeting reduces triple-negative breast cancer aggressiveness through miRNA regulation in vitro and in vivo.
Mohammadi-Yeganeh S; Hosseini V; Paryan M
J Cell Physiol; 2019 Aug; 234(10):18317-18328. PubMed ID: 30945294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
